Table 3.
Compound | Cyto-toxicity | HLM | Cyp1A2 inhibitor | Cyp3A4 inhibitor | Cyp2D6 inhibitor | Cyp2C9 inhibitor | Cyp2C19 inhibitor | BBB | P-gp inhibitor & substrate | MMP | AMES | MRTD (mg/day) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
CUCM-7 | No | Yes | No | No | No | Yes | Yes | No | No | No | No | 226 |
CUCM-14 | No | Yes | No | No | No | Yes | Yes | No | No | Yes | No | 242 |
CUCM-26 | No | Yes | No | No | No | Yes | Yes | No | No | No | No | 218 |
CUCM-36 | No | No | No | No | No | No | No | No | No | No | No | 421 |
CUCM-42 | No | Yes | No | No | No | Yes | Yes | No | No | Yes | No | 249 |
CUCM-45 | No | No | Yes | No | No | No | No | No | No | No | Yes | 406 |
Curcumin | No | Yes | No | No | No | Yes | Yes | No | No | Yes | No | 428 |
*HLM = Human Liver Microsomal Stability, Cyp1A2 = Cytochrome p450 1A2, Cyp3A4 = Cytochrome p450 3A4, Cyp2D6 = Cytochrome p450 2D6, Cyp2C9 = Cytochrome p450 2C9, Cyp2C19 = Cytochrome p450 2C19, BBB = blood brain barrier, P-gp = glycoprotein, MMP = metallo matrix protein, MRTD = maximum recommended therapeutic dose.